The business case for Far-UVC is strongest for companies with highly-paid employees. They directly bear the productivity costs not only when an employee is sick, but also when they must stay home to care for a sick child. This makes caregiver absenteeism a significant, quantifiable ROI driver.

The primary obstacle to widespread Far-UVC adoption isn't missing research, regulation, or high costs. It's a marketing and social normalization problem—shifting its perception from a niche gadget for early adopters to a standard public health utility like hand sanitizer or building ventilation.

The biggest potential failure mode for the technology is if research reveals that most common airborne disease transmission occurs at extremely short ranges (e.g., face-to-face). In such scenarios, environmental disinfection has insufficient time to neutralize pathogens before they are inhaled, limiting its overall impact.

Far-UVC is most effective at disrupting long-range airborne transmission. This makes it a powerful tool against highly contagious pandemic-level pathogens but less certain for common colds, which may be transmitted primarily at very close range where environmental disinfection has less time to work.

The first undeniable proof of Far-UVC's effectiveness won't come from complex, society-wide studies. Instead, it will come from isolated, high-risk environments like tuberculosis wards or long-term care facilities, where a 90% reduction in transmission is a clear, dramatic signal that can drive adoption.

The most effective path to widespread societal deployment is not individual sales but incorporating clean air standards into building codes. If regulations mandate a certain level of infection prevention, FAR-UVC becomes the cheapest and easiest way to comply, making it a default feature in new construction and renovations.

The primary reason FAR-UVC isn't widely deployed is a lack of public and institutional awareness. The technology is proven, commercially available, and increasingly affordable. The challenge is social diffusion and making it a normalized part of the built environment, like hand sanitizer or smoke alarms.

The technology is more effective against highly contagious pathogens like measles or pandemic viruses than less contagious ones. This is because widespread transmission offers more surface area for intervention, whereas colds often spread through prolonged, close contact where environmental disinfection is less impactful.

Far-UVC light is safe for humans not due to a complex biological interaction, but because our outer layer of dead skin cells physically absorbs the light before it can reach living tissue. This simple mechanical barrier, rather than a chemical one, is the core of its safety profile.